Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dominique Farge

Showing results (141-150 of 192) with videos related to

Pageof 20
Sort By:
Blood Advances|January 4, 2018
Evolution, trends, outcomes, and economics of hematopoietic stem cell transplantation in severe autoimmune diseasesJohn A Snowden, Manuela Badoglio, Myriam Labopin, et al.
Annals of the Rheumatic Diseases|May 22, 2015
Efficacy of sildenafil on ischaemic digital ulcer healing in systemic sclerosis: the placebo-controlled SEDUCE studyEric Hachulla, Pierre-Yves Hatron, Patrick Carpentier, et al.
The Lancet. Rheumatology|December 20, 2024
Allogeneic umbilical cord-derived mesenchymal stromal cells as treatment for systemic lupus erythematosus: a single-centre, open-label, dose-escalation, phase 1 studyDominique Farge, Lucie Biard, Ben Weil, et al.
Lancet (London, England)|February 1, 2013
Cardiac involvement and treatment-related mortality after non-myeloablative haemopoietic stem-cell transplantation with unselected autologous peripheral blood for patients with systemic sclerosis: a retrospective analysisRichard K Burt, Maria Carolina Oliveira, Sanjiv J Shah, et al.
Journal of Autoimmunity|July 23, 2013
Immunological and autoimmune considerations of Autism Spectrum DisordersBenjamin Gesundheit, Joshua P Rosenzweig, David Naor, et al.
The Lancet. Rheumatology|January 30, 2024
Safety and preliminary efficacy of allogeneic bone marrow-derived multipotent mesenchymal stromal cells for systemic sclerosis: a single-centre, open-label, dose-escalation, proof-of-concept, phase 1/2 studyDominique Farge, Séverine Loisel, Matthieu Resche-Rigon, et al.
JAMA Dermatology|June 28, 2023
Cutaneous Manifestations, Clinical Characteristics, and Prognosis of Patients With Systemic Sclerosis Sine Scleroderma: Data From the International EUSTAR DatabaseAlain Lescoat, Suiyuan Huang, Patricia E Carreira, et al.
Bulletin Du Cancer|November 28, 2017
[Indications and follow-up for autologous hematopoietic stem cell transplantation in autoimmune and autoinflammatory diseases: Guidelines from the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)]Grégory Pugnet, Christina Castilla-Llorente, Mathieu Puyade, et al.
Cytotherapy|March 3, 2026
Systemic lupus erythematosus patients eligible for chimeric antigen receptor T-cell therapy according to the 2024 EBMT and International Society for Cell and Gene Therapy expert-based recommendations: a 1-year clinical practice study in FranceMartin Nivet, Ingrid Munia, Benjamin Crichi, et al.
The Lancet. Oncology|June 30, 2022
2022 international clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer, including patients with COVID-19Dominique Farge, Corinne Frere, Jean M Connors, et al.
Pageof 20

Showing results (141-150 of 192) with videos related to

Sort By:
Pageof 20
Blood Advances|January 4, 2018
Evolution, trends, outcomes, and economics of hematopoietic stem cell transplantation in severe autoimmune diseasesJohn A Snowden, Manuela Badoglio, Myriam Labopin, et al.
Annals of the Rheumatic Diseases|May 22, 2015
Efficacy of sildenafil on ischaemic digital ulcer healing in systemic sclerosis: the placebo-controlled SEDUCE studyEric Hachulla, Pierre-Yves Hatron, Patrick Carpentier, et al.
The Lancet. Rheumatology|December 20, 2024
Allogeneic umbilical cord-derived mesenchymal stromal cells as treatment for systemic lupus erythematosus: a single-centre, open-label, dose-escalation, phase 1 studyDominique Farge, Lucie Biard, Ben Weil, et al.
Lancet (London, England)|February 1, 2013
Cardiac involvement and treatment-related mortality after non-myeloablative haemopoietic stem-cell transplantation with unselected autologous peripheral blood for patients with systemic sclerosis: a retrospective analysisRichard K Burt, Maria Carolina Oliveira, Sanjiv J Shah, et al.
Journal of Autoimmunity|July 23, 2013
Immunological and autoimmune considerations of Autism Spectrum DisordersBenjamin Gesundheit, Joshua P Rosenzweig, David Naor, et al.
The Lancet. Rheumatology|January 30, 2024
Safety and preliminary efficacy of allogeneic bone marrow-derived multipotent mesenchymal stromal cells for systemic sclerosis: a single-centre, open-label, dose-escalation, proof-of-concept, phase 1/2 studyDominique Farge, Séverine Loisel, Matthieu Resche-Rigon, et al.
JAMA Dermatology|June 28, 2023
Cutaneous Manifestations, Clinical Characteristics, and Prognosis of Patients With Systemic Sclerosis Sine Scleroderma: Data From the International EUSTAR DatabaseAlain Lescoat, Suiyuan Huang, Patricia E Carreira, et al.
Bulletin Du Cancer|November 28, 2017
[Indications and follow-up for autologous hematopoietic stem cell transplantation in autoimmune and autoinflammatory diseases: Guidelines from the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)]Grégory Pugnet, Christina Castilla-Llorente, Mathieu Puyade, et al.
Cytotherapy|March 3, 2026
Systemic lupus erythematosus patients eligible for chimeric antigen receptor T-cell therapy according to the 2024 EBMT and International Society for Cell and Gene Therapy expert-based recommendations: a 1-year clinical practice study in FranceMartin Nivet, Ingrid Munia, Benjamin Crichi, et al.
The Lancet. Oncology|June 30, 2022
2022 international clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer, including patients with COVID-19Dominique Farge, Corinne Frere, Jean M Connors, et al.
Pageof 20